Due to their homology, IDO1 and IDO2 had been thought to play redundant roles in immune responses; however, recent results from in vivo models of cancer and autoimmunity suggest that IDO2 may play a role in immune function distinct from IDO1 (6, 9). Here, IDO1 is linked to cancer.